AVIBACTAM
Background and Date of Approval
Avibactam is a non β-lactam β-lactamase inhibitor developed to combat antibiotic resistance in bacterial infections. Approved by the FDA in February 2015, it is commonly used in combination with other antibiotics to treat complicated infections. Clinical trials demonstrated its efficacy against multidrug-resistant organisms, particularly gram-negative bacteria, offering hope in an era of rising antimicrobial resistance. Avibactam has undergone rigorous testing in pivotal Phase III trials, showcasing its potential to restore the activity of β-lactam antibiotics against resistant pathogens.
Uses
Avibactam is FDA-approved for use in combination with other antibiotics to treat: Complicated intra-abdominal infections (cIAI) Complicated urinary tract infections (cUTI), including pyelonephritis Hospital-acquired bacterial pneumonia (HABP) Ventilator-associated bacterial pneumonia (VABP)
Side Effects
Common Side Effects Diarrhea Nausea and vomiting Headache Rash or itching at the injection site Serious Side Effects Anaphylaxis (severe allergic reactions) Clostridioides difficile-associated diarrhea Seizures (rare, but significant) Elevated liver enzymes (indicating liver stress)
Warnings
Severe Allergic Reactions: Avoid use in individuals with a history of hypersensitivity to β-lactam antibiotics. Renal Impairment: Dosage adjustments are critical for patients with compromised kidney function. Seizures: Risk increases in patients with central nervous system disorders. Drug Interactions: Avoid concurrent use with other nephrotoxic agents. Pregnancy and Lactation: Use only if clearly needed and under medical supervision.
Precautions
Before administering this medication, it is essential to assess the patientâs medical history, including any known allergies to penicillin or cephalosporin antibiotics. Regular renal function monitoring is advised, as improper clearance can increase toxicity risks. Administer the drug under strict medical supervision, ensuring aseptic techniques for intravenous infusion. Pregnant and breastfeeding individuals should consult a healthcare provider to weigh potential risks and benefits.
Word of Advice
Avibactam should only be used under a healthcare providerâs guidance. Maintain adequate hydration during treatment and report any unusual symptoms immediately, such as severe diarrhea or allergic reactions. Avoid self-medicating or altering dosages without consulting a doctor. Patients with existing kidney conditions should undergo regular renal monitoring during therapy. Ensure to complete the full prescribed course to prevent resistance.
References
https://go.drugbank.com/drugs/DB09060 https://pubchem.ncbi.nlm.nih.gov/compound/Avibactam https://pmc.ncbi.nlm.nih.gov/articles/PMC4187909/ https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/avibactam
Frequently Asked Questions
What is Avibactam used for?
Avibactam is used in combination with other antibiotics to treat severe bacterial infections, including complicated urinary tract infections, intra-abdominal infections, and pneumonia acquired in hospitals or on ventilators.
How is avibactam administered?
It is given as an intravenous infusion over a specific duration, typically every eight hours, depending on the infection and renal function.
Are there any dietary restrictions while taking this drug?
There are no specific dietary restrictions, but itâs recommended to maintain good hydration. Consult your doctor about any individual concerns.
When is the best time to take Avibactam?
Since itâs administered intravenously, timing is based on your healthcare providerâs schedule. Adherence to prescribed intervals is critical for effectiveness.
Does Avibactam treat all bacterial infections?
No, it is specifically effective against certain gram-negative bacteria and must be used in combination with other antibiotics.